A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Podofilox
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Deutetrabenazine.
Podofilox
Artemether
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Artemether.
Podofilox
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Tetrabenazine.
Podofilox
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Zuclopenthixol.
Podofilox
Temafloxacin
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Temafloxacin.
Podofilox
Lithium cation
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Lithium cation.
Podofilox
Cyproterone acetate
The metabolism of Pazopanib can be increased when combined with Cyproterone acetate.
Podofilox
Incadronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Pazopanib is combined with Incadronic acid.
Podofilox
Fingolimod
Pazopanib may increase the immunosuppressive activities of Fingolimod.
Podofilox
Eluxadoline
The serum concentration of Eluxadoline can be increased when it is combined with Pazopanib.
Podofilox
(S)-Warfarin
The serum concentration of (S)-Warfarin can be increased when it is combined with Pazopanib.
Podofilox
S,R-Warfarin alcohol
The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Pazopanib.
Podofilox
R,S-Warfarin alcohol
The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Pazopanib.
Podofilox
(R)-warfarin
The serum concentration of (R)-warfarin can be increased when it is combined with Pazopanib.
Podofilox
Niperotidine
The therapeutic efficacy of Pazopanib can be decreased when used in combination with Niperotidine.
Podofilox
Lavoltidine
The therapeutic efficacy of Pazopanib can be decreased when used in combination with Lavoltidine.
Podofilox
Lafutidine
The therapeutic efficacy of Pazopanib can be decreased when used in combination with Lafutidine.
Podofilox
Roxatidine acetate
The therapeutic efficacy of Pazopanib can be decreased when used in combination with Roxatidine acetate.
Podofilox
Metiamide
The therapeutic efficacy of Pazopanib can be decreased when used in combination with Metiamide.
Podofilox
Asenapine
The therapeutic efficacy of Pazopanib can be decreased when used in combination with Asenapine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3